RIBAVIRIN
RIBAVIRIN · CHRONIC HEPATITIS C - GENOTYPE 1 ·+3
AUROBINDO PHARM
Drug class
Ribavirin
Ribavirin is an active pharmaceutical ingredient rather than a distinct multi-drug therapeutic class; pharmacologically, it belongs to the broader class of synthetic guanosine nucleoside analogue antiviral agents. Read more about Ribavirin
5 drugs in this class 2 manufacturers
Drugs in Ribavirin
RIBAVIRIN
RIBAVIRIN · CHRONIC HEPATITIS C - GENOTYPE 1 ·+3
ZYDUS PHARMACEU
RIBAVIRIN
RIBAVIRIN · CHRONIC HEPATITIS C - GENOTYPE 1 ·+3
ZYDUS PHARMACEU
RIBAVIRIN
RIBAVIRIN · CHRONIC HEPATITIS C - GENOTYPE 1 ·+3
AUROBINDO PHARM
RIBAVIRIN
RIBAVIRIN · RESPIRATORY SYNCYTIAL VIRUS INFECTION
ZYDUS PHARMACEU
Filter & compare in the drug finder →
Opens the drug finder with Ribavirin preselected. Add indication or manufacturer filters there.
Ribavirin is an active pharmaceutical ingredient rather than a distinct multi-drug therapeutic class; pharmacologically, it belongs to the broader class of synthetic guanosine nucleoside analogue antiviral agents.
It exerts broad-spectrum antiviral activity through multiple proposed mechanisms, including the inhibition of host inosine monophosphate dehydrogenase, suppression of viral RNA-dependent RNA polymerase, interference with viral RNA capping, and lethal viral mutagenesis.
Therapeutically, ribavirin is utilized orally in combination regimens for the treatment of chronic hepatitis C virus infection and as an aerosolized formulation for severe lower respiratory tract infections caused by respiratory syncytial virus.
-
fda.gov
Ribavirin is an active pharmaceutical ingredient rather than a distinct multi-drug therapeutic class; pharmacologically, it belongs to the broader class of synthetic guanosine nucleoside analogue antiviral agents
-
nih.gov
Ribavirin is an active pharmaceutical ingredient rather than a distinct multi-drug therapeutic class; pharmacologically, it belongs to the broader class of synthetic guanosine nucleoside analogue antiviral agents Therapeutically, ribavirin is utilized orally in combination regimens for the treatment of chronic hepatitis C virus infection and as an aerosolized formulation for severe lower respiratory tract infections caused by respiratory syncytial virus
-
nih.gov
Ribavirin is an active pharmaceutical ingredient rather than a distinct multi-drug therapeutic class; pharmacologically, it belongs to the broader class of synthetic guanosine nucleoside analogue antiviral agents
-
nih.gov
Ribavirin is an active pharmaceutical ingredient rather than a distinct multi-drug therapeutic class; pharmacologically, it belongs to the broader class of synthetic guanosine nucleoside analogue antiviral agents
-
drugbank.com
It exerts broad-spectrum antiviral activity through multiple proposed mechanisms, including the inhibition of host inosine monophosphate dehydrogenase, suppression of viral RNA-dependent RNA polymerase, interference with viral RNA capping, and lethal viral mutagenesis
-
nih.gov
It exerts broad-spectrum antiviral activity through multiple proposed mechanisms, including the inhibition of host inosine monophosphate dehydrogenase, suppression of viral RNA-dependent RNA polymerase, interference with viral RNA capping, and lethal viral mutagenesis Therapeutically, ribavirin is utilized orally in combination regimens for the treatment of chronic hepatitis C virus infection and as an aerosolized formulation for severe lower respiratory tract infections caused by respiratory sy...
-
fda.gov
Therapeutically, ribavirin is utilized orally in combination regimens for the treatment of chronic hepatitis C virus infection and as an aerosolized formulation for severe lower respiratory tract infections caused by respiratory syncytial virus
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.